HLA-C and urinary bladder cancer: Despite different cellular origin, STOSE and MOE tumors had high expression of MHC-II and PD-L1, which may be a particularity of the FVB/N genetic background as similar findings on MHC and PD-L1 expression were observed in bladder cancer (35).